Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Rapid distribution of liposomal short-chain ceramide in vitro and in vivo.

Zolnik BS, Stern ST, Kaiser JM, Heakal Y, Clogston JD, Kester M, McNeil SE.

Drug Metab Dispos. 2008 Aug;36(8):1709-15. doi: 10.1124/dmd.107.019679. Epub 2008 May 19.

2.

Systemic delivery of liposomal short-chain ceramide limits solid tumor growth in murine models of breast adenocarcinoma.

Stover TC, Sharma A, Robertson GP, Kester M.

Clin Cancer Res. 2005 May 1;11(9):3465-74.

3.

PLGA/liposome hybrid nanoparticles for short-chain ceramide delivery.

Zou P, Stern ST, Sun D.

Pharm Res. 2014 Mar;31(3):684-93. doi: 10.1007/s11095-013-1190-5. Epub 2013 Sep 25.

4.

Liposomal delivery enhances short-chain ceramide-induced apoptosis of breast cancer cells.

Stover T, Kester M.

J Pharmacol Exp Ther. 2003 Nov;307(2):468-75. Epub 2003 Sep 15.

5.

Encapsulation of foscarnet in liposomes modifies drug intracellular accumulation, in vitro anti-HIV-1 activity, tissue distribution and pharmacokinetics.

Dusserre N, Lessard C, Paquette N, Perron S, Poulin L, Tremblay M, Beauchamp D, Désormeaux A, Bergeron MG.

AIDS. 1995 Aug;9(8):833-41.

PMID:
7576316
7.

High ceramide content liposomes with in vivo antitumor activity.

Shabbits JA, Mayer LD.

Anticancer Res. 2003 Sep-Oct;23(5A):3663-9.

PMID:
14666662
8.

The effect of PEG coating on in vitro cytotoxicity and in vivo disposition of topotecan loaded liposomes in rats.

Dadashzadeh S, Vali AM, Rezaie M.

Int J Pharm. 2008 Apr 2;353(1-2):251-9. doi: 10.1016/j.ijpharm.2007.11.030. Epub 2007 Nov 23.

PMID:
18191511
10.

Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.

Du J, Lu WL, Ying X, Liu Y, Du P, Tian W, Men Y, Guo J, Zhang Y, Li RJ, Zhou J, Lou JN, Wang JC, Zhang X, Zhang Q.

Mol Pharm. 2009 May-Jun;6(3):905-17. doi: 10.1021/mp800218q.

PMID:
19344115
11.
12.

Transferrin-conjugated liposomal system for improved delivery of 5-fluorouracil to brain.

Soni V, Kohli DV, Jain SK.

J Drug Target. 2008 Jan;16(1):73-8. doi: 10.1080/10611860701725381 .

PMID:
18172823
13.

Pharmacokinetics and tissue distribution of liposomal etoposide in rats.

Sistla A, Smith DJ, Kobrinsky NL, Kumar K.

Drug Deliv. 2009 Nov;16(8):423-9. doi: 10.3109/10717540903223418.

PMID:
19839786
14.

Pharmacokinetic evaluation of liposomal encapsulated ampicillin in male and female rats.

Pardue RL, White CA.

Biopharm Drug Dispos. 1997 May;18(4):279-92.

PMID:
9158877
16.

Intraoperative therapy with liposomal drug delivery: retention and distribution in human head and neck squamous cell carcinoma xenograft model.

Wang SX, Bao A, Phillips WT, Goins B, Herrera SJ, Santoyo C, Miller FR, Otto RA.

Int J Pharm. 2009 May 21;373(1-2):156-64. doi: 10.1016/j.ijpharm.2009.02.009. Epub 2009 Feb 21.

PMID:
19429301
17.

Amphipathic weak acid glucocorticoid prodrugs remote-loaded into sterically stabilized nanoliposomes evaluated in arthritic rats and in a Beagle dog: a novel approach to treating autoimmune arthritis.

Avnir Y, Ulmansky R, Wasserman V, Even-Chen S, Broyer M, Barenholz Y, Naparstek Y.

Arthritis Rheum. 2008 Jan;58(1):119-29. doi: 10.1002/art.23230.

18.

PEGylated liposomes loading palmitoyl prednisolone for prolonged blood concentration of prednisolone.

Teshima M, Kawakami S, Fumoto S, Nishida K, Nakamura J, Nakashima M, Nakagawa H, Ichikawa N, Sasaki H.

Biol Pharm Bull. 2006 Jul;29(7):1436-40.

19.

Transferrin coupled liposomes as drug delivery carriers for brain targeting of 5-florouracil.

Soni V, Kohli DV, Jain SK.

J Drug Target. 2005 May;13(4):245-50.

PMID:
16051536
20.

Dihydroceramide hinders ceramide channel formation: Implications on apoptosis.

Stiban J, Fistere D, Colombini M.

Apoptosis. 2006 May;11(5):773-80.

PMID:
16532372

Supplemental Content

Support Center